Research output per year
Research output per year
PROF.DR., Principal Investigator
Research activity per year
Immunotherapy, cancer, inflammatory diseases, antibodies, immunology
Since the start of her career Prof. dr. van Egmond has studied the function of antibodies, with emphasis on understanding the role of immunoglobulin A (IgA) in physiology and pathology. Her research also addresses (1) the contribution of abnormal antibody responses in chronic inflammation and autoimmunity and (2) monoclonal antibody therapy of cancer. Prof. dr. van Egmond’s research is highly translational and she has a cross appointment with the Department of Surgery and the Department of Molecular Cell Biology and Immunology at Amsterdam UMC, to facilitate the rapid progression of pre-clinical findings into clinical applications. Prof.dr. van Egmond is the spokeswoman of the Dutch Society for Immunology, and since the COVID-19 crisis she has an active role in providing information on the immune system and vaccines to the general public.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
Research output: Contribution to journal › Review article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
van Egmond, M. (Member)
Activity: Membership › Membership of board › Academic
van Egmond, M. (Speaker)
Activity: Talk or presentation › Invited talk › Academic
van Egmond, M. (Speaker)
Activity: Talk or presentation › Invited talk › Academic
van Egmond, M. (Speaker)
Activity: Talk or presentation › Invited talk › Academic
van Egmond, M. (Consultant)
Activity: Consultancy › Academic
02/11/2023
1 Media contribution
Press/Media: Press / Media
01/11/2023
1 Media contribution
Press/Media: Press / Media